Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19)

被引:0
|
作者
Jeroen J. A. van Kampen
David A. M. C. van de Vijver
Pieter L. A. Fraaij
Bart L. Haagmans
Mart M. Lamers
Nisreen Okba
Johannes P. C. van den Akker
Henrik Endeman
Diederik A. M. P. J. Gommers
Jan J. Cornelissen
Rogier A. S. Hoek
Menno M. van der Eerden
Dennis A. Hesselink
Herold J. Metselaar
Annelies Verbon
Jurriaan E. M. de Steenwinkel
Georgina I. Aron
Eric C. M. van Gorp
Sander van Boheemen
Jolanda C. Voermans
Charles A. B. Boucher
Richard Molenkamp
Marion P. G. Koopmans
Corine Geurtsvankessel
Annemiek A. van der Eijk
机构
[1] Erasmus MC,Department of Viroscience
[2] Subdivision Infectious Diseases and Immunology,Department of Pediatrics
[3] Erasmus MC - Sophia,Department of Intensive Care
[4] Erasmus MC,Department of Hematology
[5] Erasmus MC,Department of Pulmonary Medicine
[6] Erasmus MC,Department of Internal Medicine, Division of Nephrology and Transplantation
[7] Erasmus MC Transplant Institute,Department of Gastroenterology and Hepatology
[8] Erasmus MC,Department of Medical Microbiology and Infectious Diseases
[9] Erasmus MC,undefined
[10] Erasmus MC,undefined
来源
Nature Communications | / 12卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Key questions in COVID-19 are the duration and determinants of infectious virus shedding. Here, we report that infectious virus shedding is detected by virus cultures in 23 of the 129 patients (17.8%) hospitalized with COVID-19. The median duration of shedding infectious virus is 8 days post onset of symptoms (IQR 5–11) and drops below 5% after 15.2 days post onset of symptoms (95% confidence interval (CI) 13.4–17.2). Multivariate analyses identify viral loads above 7 log10 RNA copies/mL (odds ratio [OR] of 14.7 (CI 3.57-58.1; p < 0.001) as independently associated with isolation of infectious SARS-CoV-2 from the respiratory tract. A serum neutralizing antibody titre of at least 1:20 (OR of 0.01 (CI 0.003-0.08; p < 0.001) is independently associated with non-infectious SARS-CoV-2. We conclude that quantitative viral RNA load assays and serological assays could be used in test-based strategies to discontinue or de-escalate infection prevention and control precautions.
引用
收藏
相关论文
共 50 条
  • [21] Pneumothorax and pneumomediastinum in patients hospitalized with coronavirus disease 2019 (COVID-19)
    Greenberg, Daniel J.
    Nabors, Christopher
    Chandy, Dipak
    Dhand, Abhay
    HEART & LUNG, 2021, 50 (03): : 386 - 387
  • [22] CORONARYARTERY DISEASE IN PATIENTS HOSPITALIZED WITH CORONAVIRUS DISEASE 2019 (COVID-19) INFECTION
    Loffi, M.
    Piccolo, R.
    Regazzoni, V.
    Di Tano, G.
    Moschini, L.
    Robba, D.
    Esposito, D.
    Franzone, A.
    Danzi, G.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (0C) : C15 - C15
  • [23] Duration of infectious virus shedding in patients with severe coronavirus disease 2019 who required mechanical ventilation
    Nomura, Toshihito
    Kitagawa, Hiroki
    Omori, Keitaro
    Shigemoto, Norifumi
    Kakimoto, Masaki
    Nazmul, Tanuza
    Shime, Nobuaki
    Sakaguchi, Takemasa
    Ohge, Hiroki
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2022, 28 (01) : 19 - 23
  • [24] Environmental Determinants of Coronavirus Disease 2019 (COVID-19)
    Eric B. Brandt
    Tesfaye B. Mersha
    Current Allergy and Asthma Reports, 2021, 21
  • [25] Environmental Determinants of Coronavirus Disease 2019 (COVID-19)
    Brandt, Eric B.
    Mersha, Tesfaye B.
    CURRENT ALLERGY AND ASTHMA REPORTS, 2021, 21 (03)
  • [26] Pulmonary embolism in patients with coronavirus disease-2019 (COVID-19) pneumonia: a narrative review
    Yasser Sakr
    Manuela Giovini
    Marc Leone
    Giacinto Pizzilli
    Andreas Kortgen
    Michael Bauer
    Tommaso Tonetti
    Gary Duclos
    Laurent Zieleskiewicz
    Samuel Buschbeck
    V. Marco Ranieri
    Elio Antonucci
    Annals of Intensive Care, 10
  • [27] Pulmonary embolism in patients with coronavirus disease-2019 (COVID-19) pneumonia: a narrative review
    Sakr, Yasser
    Giovini, Manuela
    Leone, Marc
    Pizzilli, Giacinto
    Kortgen, Andreas
    Bauer, Michael
    Tonetti, Tommaso
    Duclos, Gary
    Zieleskiewicz, Laurent
    Buschbeck, Samuel
    Ranieri, V. Marco
    Antonucci, Elio
    ANNALS OF INTENSIVE CARE, 2020, 10 (01)
  • [28] Gastrointestinal manifestations in patients with coronavirus disease-2019 (COVID-19): Impact on clinical outcomes
    Tabesh, Elham
    Soheilipour, Maryam
    Sami, Ramin
    Mansourian, Marjan
    Tabesh, Faezeh
    Soltaninejad, Forogh
    Dehghan, Mehrnegar
    Nikgoftar, Niloofar
    Gharavinia, Ali
    Ghasemi, Khojasteh
    Adibi, Peyman
    JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2022, 27 (01): : 32
  • [29] Will an obesity pandemic replace the coronavirus disease-2019 (COVID-19) pandemic?
    Ghanemi, Abdelaziz
    Yoshioka, Mayumi
    St-Amand, Jonny
    MEDICAL HYPOTHESES, 2020, 144
  • [30] Traumatic Injuries Management in Coronavirus Disease-2019 (COVID-19) Crisis
    Rasouli, Hamid Reza
    Khoshmohabat, Hadi
    Ahmadpour, Fathollah
    TRAUMA MONTHLY, 2020, 25 (03) : 96 - 96